Publications & Works

Publication Network
Articles Published in Other Journals

Genetic heterogeneity and metabolic reprogramming in breast cancer

DOLAŞ Y., BURUŞ A., ÇELTİKÇİ B.
Acta Medica , vol.55, no.4, pp.1-20, 2024 (Peer-Reviewed Journal)

The effect of genetics and biochemistry on the pathogenesis of cholangiocarcinoma

ÜÇDAL M. T., BURUŞ A., ÇELTİKÇİ B.
INTERNATIONAL JOURNAL OF HEPATOBILIARY AND PANCREATIC DISEASES , vol.14, no.2, pp.1-14, 2024 (ESCI) identifier

Cross Talk Between Genetics and Biochemistry in The Pathogenesis of Hepatocellular Carcinoma

ÜÇDAL M. T., BURUŞ A., ÇELTİKÇİ B.
Hepatology forum , vol.5, no.3, pp.150-160, 2024 (ESCI) identifier identifier identifier
Papers Presented at Peer-Reviewed Scientific Conferences

The Cytokine Profile of Primary Biliary Cholangitis (PBC): Is PBC an Autoinflammatory vs. Autoimmune Disease?

RADGOHAR A., ÜÇDAL M. T., BURUŞ A., YALÇINKAYA A., BALABAN H. Y., ÇELTİKÇİ B.
41. Ulusal Gastroenteroloji Haftası, Antalya, Turkey, 27 November 2024, (Summary Text)

Two forms of a disease in the same family: compound heterozygosity in the father and his sister both with corneal cystinosis, and heterozygous daughter and his other sister both having risks for nephropathic cystinosis

ÇELTİKÇİ B., Kazancı B.
European Human Genetics Virtual Conference, Berlin, Germany, 06 June 2020, (Full Text)

Two families having Huntington’xxs disease with two different clinical presentations

ÇELTİKÇİ B., Kaplan F., SAYIN R.
EUROPEAN HUMAN GENETICS CONFERENCE, Gothenburg, Sweden, 15 - 18 June 2019, vol.27, pp.1865, (Full Text)

The effects of human chorionic gonadotropin-based hormonal therapy on the expression levels of proliferating cell nuclear antigen

ÇELTİKÇİ B., TANGAL S., ÖZER L.
13. Balkan Congress of Human Genetics, 17 - 20 April 2019, (Full Text)

The role of JAK1/2-STAT3 as acute resistance mechanism to MEK inhibition in BRAF-mutant colorectal cancer cell lines.

ÇELTİKÇİ B., Carson R., Johnston P. G., Van Schaeybroeck S.
JOURNAL OF CLINICAL ONCOLOGY, Chicago, 30 May - 03 June 2014, vol.32 Sustainable Development

The role of JAK1/2-STAT3 as acute resistance mechanism to MEK inhibition in BRAF mutant colorectal cancer

Carson R., ÇELTİKÇİ B., Johnston P. G., Van Schaeybroeck S., Dunne P.
MOLECULAR CANCER THERAPEUTICS, 10 - 13 November 2013, vol.12 Sustainable Development

The establishment of Green Fluorescent Protein expressing CHO cells by stable transfection using activated dendrimers and G418 selection

ÇELTİKÇİ B., ÖZKARA H. A., PURALI N.
FEBS JOURNAL, Prague, 4 - 09 July 2009, vol.276, pp.215-216

Increased hexosaminidase activity in psychiatric patients with drug induced extrapramidal side effects

Tunca Z., Resmi H., Ozkara A., Ciliv G., Celtikci B., Alptekin K., et al.
62nd Annual Scientific Meeting of the Society-of-Biological-Psychiatry, California, United States Of America, 01 January 2007, vol.61, (Summary Text) identifier

Protective role of 27 bp deletion polymorphism in intron 4 of eNOS gene in cerebral small-vessel disease

Yemisci M., Sinici I., ÖZKARA H. A., HAYRAN K. M., ay h., ÇELTİKÇİ B., et al.
FEBS JOURNAL, İstanbul, Turkey, 24 - 29 June 2006
Metrics

Publication

23

Citation (WoS)

104

H-Index (WoS)

5

Citation (Scopus)

136

H-Index (Scopus)

6

Citation (Scholar)

1

H-Index (Scholar)

1

Project

7

Open Access

2
UN Sustainable Development Goals